Long Term Outcome Data from the Eortc 75111-10114 Etf/Bcg Randomized Phase Ii Study: Pertuzumab and Trastuzumab with or Without Metronomic Chemotherapy for Older Patients with Her2-Positive Metastatic Breast Cancer, Followed by T-Dm1 After Progression

AuthID
 P-00W-R9F
12
Author(s)
Wildiers, H
·
Meyskens, T
·
Marreaud, S
·
Dal Lago, L
·
Vuylsteke, P
·
Curigliano, G
·
Waters, S
·
Brouwers, B
·
Meulemans, B
·
Poncet, C
·
Brain, E
Tipo de Documento
Article
Year published
2022
Publicado
in BREAST, ISSN: 0960-9776
Volume: 64, Páginas: 100-111 (12)
Indexing
Wos®
Scopus®
Crossref®6
Pubmed®
Google Scholar®
Publication Identifiers
Pubmed: 35636341
SCOPUS: 2-s2.0-85131036839
Wos: WOS:000807506100004
Source Identifiers
ISSN: 0960-9776
Export Publication Metadata
Lista Marked
 Adicionar à lista Marked
Info
At this moment we don't have any links to full text documens.

Um espaço para investigadores e suas Instituições

Links Úteis

Ajuda

© 2024 CRACS & Inesc TEC - All Rights Reserved Política de Privacidade | Terms of Service